# South Korea Depression Screening Mental Health Market > South Korea Depression Screening Mental Health Market Research Report By Indication (Major Depressive Disorder, Anxiety Distress, Bipolar Disorder, Psychotic Disorders, Others), By Diagnosis (Psychological Tests, Blood Tests, Pharmacogenomic Testing, Others) and By End User (Hospitals and Clinics, Home-based, Research and Academic Institutes) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.15% - **2024:** $ 18.26 Million - **2025:** $ 19.02 Million - **2035:** $ 28.56 Million - **Key Players:** UnitedHealth Group (US), Anthem (US), Cigna (US), Kaiser Permanente (US), Teladoc Health (US), Mayo Clinic (US), HCA Healthcare (US), Cerner Corporation (US), McKesson Corporation (US) **Report ID:** MRFR/HC/54516-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-depression-screening-mental-health-market-56282 --- ## Market Summary ## **South Korea Depression Screening Mental Health Market Overview** As per MRFR analysis, the South Korea Depression Screening Mental Health Market Size was estimated at 17.24 (USD Million) in 2024.The South Korea Depression Screening Mental Health Market Industry is expected to grow from 45.5(USD Million) in 2025 to 91 (USD Million) by 2035. The South Korea Depression Screening Mental Health Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035) **Key South Korea Depression Screening Mental Health Market Trends Highlighted** The South Korea Depression Screening Mental Health Market is experiencing significant shifts driven by a heightened awareness of mental health issues among the population. Increased national campaigns advocating for mental health awareness are transforming societal attitudes towards depression, reducing the stigma associated with seeking help. This growing openness is fueled by government initiatives that have prioritized mental health services, resulting in increased funding and resources for screening programs.  Collaborative efforts between healthcare providers and technology companies are leading to the development of innovative screening tools, such as smartphone apps and online assessment platforms, making it easier for individuals to access mental health screenings.In recent times, there a noticeable trend toward integrating mental health services within primary healthcare settings. The South Korean government has recognized the importance of early detection and intervention, prompting healthcare providers to incorporate depression screening into routine health check-ups. This approach not only increases accessibility but also emphasizes a holistic view of health that includes mental well-being.  Moreover, there's an emerging opportunity screening programs to different demographics, such as the elderly and adolescents, who may exhibit unique patterns of depression. Furthermore, the rise of telemedicine has opened new avenues for remote mental health evaluations, offering convenience and confidentiality in a culturally sensitive manner.South Korea's tech-savvy population is particularly receptive to using digital platforms for healthcare, which enhances the reach of depression screening initiatives.  Overall, these trends highlight a growing recognition of mental health's significance and the potential for comprehensive strategies to address depression in South Korea, paving the way for innovative solutions and greater public engagement in mental health care. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **South Korea Depression Screening Mental Health Market Drivers** **Increasing Prevalence of Depression Disorders in South Korea** The South Korea Depression Screening Mental Health Market Industry is witnessing significant growth due to the rising prevalence of depression among the population. According to recent data from the Korean National Health Insurance Service, the number of people diagnosed with depression in South Korea has risen by 27% over the last five years, accounting for approximately 1.6 million individuals in 2022.  This upward trend is primarily driven by societal factors such as high unemployment rates and increasing levels of stress, particularly among the younger generations.The South Korean government has recognized mental health as a priority, launching several initiatives aimed at increasing awareness and improving access to mental health services.  Established organizations like the Korean Neuropsychiatric Association are also advocating for better screening practices and treatment options, further bolstering the market as more individuals seek diagnosis and care for their mental health conditions. As the demand for effective depression screening tools and methodologies increases, the market is likely to expand significantly. **Government Initiatives and Mental Health Policies** The South Korean government has made substantial strides in enhancing mental health care through key policy reforms and initiatives focused on mental health. In 2020, the Ministry of Health and Welfare implemented the 'Mental Health Enhancement Plan,' which aims to promote awareness, prevention, and treatment of mental health disorders, including depression.  These government-backed initiatives are leading to increased funding for mental health services, resulting in a more supportive environment for the South Korea Depression Screening Mental Health Market Industry.Furthermore, the government’s commitment to integrating mental health care into primary health services is expected to drive accessibility and screening efforts, thus propelling market growth. **Rising Awareness and Stigma Reduction** In South Korea, there is a growing awareness of mental health issues, with efforts focused on reducing the stigma associated with mental illness. Campaigns led by various non-governmental organizations and public figures have successfully increased public dialogue about depression and mental health, encouraging individuals to seek diagnosis and treatment.  Surveys indicate that there has been a noted increase in people willing to discuss mental health openly, with around 40% of individuals expressing openness to talking about their mental health in recent years.As a consequence of changing market dynamics, clinics such as the Mental Health Centre Crisis Counselling provide integrated education and awareness services on mental health, which in turn increases the use of depression screening services. **Technological Advancements in Screening Tools** Technological innovations are contributing significantly to the growth of the South Korea Depression Screening Mental Health Market Industry. The emergence of digital tools and applications designed specifically for mental health assessments has enhanced the effectiveness and accessibility of depression screenings. Recent advancements include the use of artificial intelligence that facilitates accurate analysis and diagnosis based on patient responses. The Korea Institute of Mental Health is actively involved in promoting the use of technology in mental health assessments. With the integration of these innovative tools into healthcare systems, the market for depression screening is expected to see an accelerated growth trajectory, leading to wider acceptance and usage across healthcare facilities. **South Korea Depression Screening Mental Health Market Segment Insights** **Depression Screening Mental Health Market Indication Insights** The South Korea Depression Screening Mental Health Market is an evolving sector addressing the increasing prevalence of mental health conditions, particularly focusing on indications such as Major Depressive Disorder, Anxiety Distress, Bipolar Disorder, and Psychotic Disorders, among others. This market is characterized by an upward trajectory fueled by rising awareness of mental health issues and the importance of early detection through effective screening. Major Depressive Disorder, known for its debilitating effects, holds a significant share of the market, as it directly disrupts daily functioning and quality of life. Health professionals are increasingly emphasizing its impact on productivity and overall health, thereby driving demand for accurate screening tools. Anxiety Distress continues to gain attention as society grapples with the fast-paced lifestyle and stress, underscoring the need for effective screening mechanisms to identify those at risk and ensure timely intervention. Bipolar Disorder, marked by extreme mood swings, requires a specialized approach for screening due to its complex nature. The increase in bipolar diagnoses in South Korea highlights the necessity for tailored screening methods, reflecting the growing recognition of nuanced mental health challenges. Psychotic Disorders, including schizophrenia, significantly impact familial and social relations and necessitate early intervention strategies. Screening for these conditions is critical, as it aids in prompt treatment initiation, ultimately reducing long-term healthcare costs and enhancing patient outcomes. Lastly, the 'Others' category encapsulates various less common mental health issues that still require attention, further diversifying the screening landscape. Overall, the South Korea Depression Screening Mental Health Market is transitioning towards more comprehensive approaches, aligning with global trends in mental health care while addressing unique local challenges and opportunities. The convergence of technological advancements, coupled with government initiatives aimed at improving mental health awareness and services, positions the market for significant growth in the coming years, reflecting the imperative nature of mental health screening in the nation's healthcare agenda. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Depression Screening Mental Health Market Diagnosis Insights** The Diagnosis segment of the South Korea Depression Screening Mental Health Market plays a crucial role in identifying and managing depression effectively. Within this segment, Psychological Tests are essential as they utilize standardized questionnaires and assessments to evaluate mental health status and help healthcare providers tailor treatment plans. Blood Tests have gained importance as they seek to analyze biochemical markers, aiding in understanding the physiological aspects influencing depression. Pharmacogenomic Testing has emerged as a significant method to determine individual responses to various antidepressant medications, thereby optimizing treatment strategies and minimizing adverse effects. Additionally, other evaluation methods contribute to a comprehensive diagnostic approach, addressing diverse patient needs. This segment is driven by the increasing prevalence of depression in South Korea, supported by initiatives from the Korean government focusing on mental health awareness and improving access to mental health services. The continued analysis and investment in these diagnostic methods align with the growing need for effective and personalized treatments, reflecting a significant positive shift in the mental health landscape of the region. **Depression Screening Mental Health Market End User Insights** The ser segment of the South Korea Depression Screening Mental Health Market plays a crucial role in the overall healthcare landscape, particularly as the prevalence of mental health issues continues to rise in the country. Hospitals and clinics serve as primary access points for individuals seeking screening and treatment for depression, supported by a growing number of healthcare professionals specializing in mental health. Home-based care is also gaining traction, driven by the increasing demand for convenient and personalized mental health services, allowing patients to receive care in familiar surroundings. Research and academic institutes contribute significantly to the South Korea Depression Screening Mental Health Market by advancing knowledge and developing innovative screening tools and methodologies. This synergy between clinical practice and research is essential for improving depression screening rates and treatment outcomes, emphasizing the importance of each segment in the broader mental health ecosystem. As mental health awareness continues to grow in South Korea, supported by various government and health initiatives, each End User category is expected to evolve, responding to the changing needs of the population and improving accessibility to essential mental health services. **South Korea Depression Screening Mental Health Market Key Players and Competitive Insights** The South Korea Depression Screening Mental Health Market is characterized by a growing awareness of mental health issues and an increasing demand for effective screening and treatment services. The market comprises various players, including hospitals, specialized clinics, and mental health organizations that focus on innovative approaches for identifying and addressing depression. The competitive landscape reveals a mix of established institutions and emerging entities, each leveraging technology, research, and community outreach to enhance their service offerings. Factors such as government support, increasing healthcare expenditure, and advances in diagnostic tools substantially contribute to the growth of this market segment, shaping strategies as organizations respond to the evolving needs of patients and healthcare providers. Inje University Busan Paik Hospital plays a pivotal role in the South Korea Depression Screening Mental Health Market, boasting a strong reputation and extensive resources dedicated to mental health services. The hospital is known for its comprehensive approach to diagnosing and treating depression, including the integration of advanced screening tools that allow for early detection and personalized treatment plans. Inje University Busan Paik Hospital’s multidisciplinary teams work collaboratively to provide holistic care to patients, ensuring that both psychological and physical health are addressed. The institution’s commitment to research and continuous improvement also enhances its standing in the market, making it a trusted provider essential to the overall mental health landscape in South Korea. The Korean Institute of Mental Health holds a significant position in the South Korea Depression Screening Mental Health Market, focusing on research, clinical services, and community mental health initiatives. It emphasizes the development and implementation of innovative screening tools and therapeutic methodologies that cater specifically to the needs of individuals struggling with depression. The institute is well-respected for its evidence-based practices and outreach programs that promote awareness and understanding of mental health issues in society.  With a robust network and collaborations with various stakeholders, Korean Institute of Mental Health is positioned strategically to influence mental health policies and practices across the region. Ongoing partnerships and potential mergers or collaborations further strengthen its capacity to enhance service delivery and expand its reach in the South Korean market. **Key Companies in the South Korea Depression Screening Mental Health Market Include** - Inje University Busan Paik Hospital - Korean Institute of Mental Health - Daejeon Mental Health Center - Chonnam National University Hospital - Seoul National University Hospital - Asan Medical Center - Konkuk University Medical Center - Mental Health Center - Korea University Anam Hospital - Yonsei University Health System - Pusan National University Hospital - Sungkyunkwan University School of Medicine - Hallym University Medical Center - Samsung Medical Center **South Korea Depression Screening Mental Health Market Industry Developments** Recent developments in the South Korea Depression Screening Mental Health Market highlight a growing need for mental health services amid increasing awareness regarding mental health issues. Asan Medical Center and Seoul National University Hospital have launched new initiatives focusing on early detection and screening for depression, aiming to improve patient outcomes through advanced technology and collaboration with community health organizations. In October 2023, Hallym University Medical Center signed a partnership agreement with Konkuk University Medical Center to enhance mental health services, thereby expanding their capabilities in depression screening and treatment. Moreover, the Korean Institute of Mental Health has reported significant growth in the market due to government support for mental health initiatives, with funding aimed at boosting research and development in this sector. Current affairs also reveal that Samsung Medical Center is incorporating artificial intelligence tools into their screening processes, promising higher accuracy and efficiency. Over the past few years, the South Korean government has prioritized mental health, responding to increasing depression ratesevidenced by a reported increase in patients seeking help at facilities like the Daejeon Mental Health Center and Chonnam National University Hospital, emphasizing the urgent need for expanded services and resources. **South Korea Depression Screening Mental Health Market Segmentation Insights** **Depression Screening Mental Health Market Indication****Outlook** - Major Depressive Disorder - Anxiety Distress - Bipolar Disorder - Psychotic Disorders - Others **Depression Screening Mental Health Market Diagnosis****Outlook** - Psychological Tests - Blood Tests - Pharmacogenomic Testing - Others **Depression Screening Mental Health Market End User****Outlook** - Hospitals and Clinics - Home-based - Research and Academic Institutes ## Market Drivers ### Government Funding and Support Government funding and support for mental health initiatives in South Korea play a crucial role in shaping the depression screening-mental-health market. Recent allocations have focused on enhancing mental health services, including screening programs aimed at early detection and intervention. In 2025, the government announced a budget increase of 15% for mental health services, which is expected to facilitate the development and implementation of innovative screening tools. This financial backing not only enhances accessibility but also encourages collaboration between public and private sectors, fostering a more robust infrastructure for mental health care. As a result, the depression screening-mental-health market is likely to experience growth driven by these supportive measures. ### Rising Mental Health Awareness The increasing awareness surrounding mental health issues in South Korea is a pivotal driver for the depression screening-mental-health market. Public campaigns and educational programs have contributed to a cultural shift, encouraging individuals to seek help for mental health concerns. According to recent surveys, approximately 30% of South Koreans acknowledge experiencing symptoms of depression, highlighting the need for effective screening methods. This growing recognition of mental health challenges is likely to propel demand for screening services and tools, as individuals become more proactive in addressing their mental well-being. The depression screening-mental-health market is thus positioned to benefit from this heightened awareness, as more people seek out resources and support for their mental health needs. ### Increased Focus on Preventive Care There is a notable shift towards preventive care in South Korea, which significantly impacts the depression screening-mental-health market. Health professionals and policymakers are increasingly recognizing the importance of early detection and intervention in mental health issues. This proactive approach is reflected in the implementation of routine screening programs in various settings, including schools and workplaces. Research indicates that early intervention can reduce the severity of depression symptoms by up to 50%, underscoring the value of preventive measures. As a result, the depression screening-mental-health market is likely to see a surge in demand for screening services that align with this preventive care paradigm. ### Cultural Shifts Towards Mental Health Cultural shifts in South Korea are gradually changing perceptions of mental health, which is a significant driver for the depression screening-mental-health market. Historically, mental health issues have been stigmatized, but recent trends indicate a growing acceptance of mental health discussions. This change is particularly evident among younger generations, who are more open to seeking help and discussing their mental health challenges. Surveys show that 60% of young adults are willing to engage in conversations about mental health, which is likely to increase the demand for screening services. As societal attitudes continue to evolve, the depression screening-mental-health market is expected to benefit from this cultural transformation. ### Integration of Digital Health Solutions The integration of digital health solutions into the depression screening-mental-health market is transforming how mental health services are delivered in South Korea. With the rise of telehealth platforms and mobile applications, individuals can now access screening tools and mental health resources from the comfort of their homes. This shift is particularly relevant in urban areas, where busy lifestyles may hinder traditional in-person consultations. Data indicates that the use of digital mental health tools has increased by 40% in the past year, suggesting a growing acceptance of technology in mental health care. Consequently, the depression screening-mental-health market is likely to expand as more individuals utilize these innovative solutions for screening and support. ## Future Outlook The [Depression Screening Mental Health Market](https://www.marketresearchfuture.com/reports/depression-screening-mental-health-market-3806) is projected to grow at a 4.15% CAGR from 2025 to 2035, driven by increasing awareness and technological advancements. **New opportunities:** - Development of AI-driven diagnostic tools for early detection. - Expansion of telehealth services to reach underserved populations. - Integration of mental health screenings in primary care settings. By 2035, the market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Indication: Major Depressive Disorder (Largest) vs. Anxiety Distress (Fastest-Growing) In the South Korea depression screening-mental-health market, Major Depressive Disorder currently holds the largest market share, reflecting the significant prevalence of this condition among the population. Following closely, Anxiety Distress also represents a substantial portion of the market, showcasing the rising awareness and diagnosis of anxiety-related issues. Other segments such as Bipolar Disorder and Psychotic Disorders contribute to the market but are comparatively smaller in terms of market share. Looking ahead, the growth trends in this market segment indicate a rapid increase in demand for screening and treatment options, especially for Anxiety Distress, which is considered the fastest-growing area. The drivers of this growth include heightened societal awareness of mental health, increased accessibility to mental health services, and ongoing research and advancements in screening methodologies that enhance early detection and intervention. Additionally, governmental and non-governmental initiatives to destigmatize mental health issues are encouraging more individuals to seek help and undergo screening. Major Depressive Disorder (Dominant) vs. Anxiety Distress (Emerging) Major Depressive Disorder remains the dominant segment of the South Korea depression screening-mental-health market due to its high prevalence and the comprehensive treatment options available. This disorder is often characterized by persistent sadness, loss of interest, and numerous cognitive impairments, necessitating effective screening and intervention strategies. On the other hand, Anxiety Distress is emerging as a significant area of focus, driven by increasing awareness of anxiety disorders, which are now recognized as critical mental health issues. The anxiety segment is characterized by varied symptoms such as excessive worry and tension, influencing an individual's daily functioning. As mental health initiatives grow, the demand for accurate screening and tailored treatments for both segments will continue to evolve, shaping the future landscape of mental health care. ### By Diagnosis: Psychological Tests (Largest) vs. Blood Tests (Fastest-Growing) In the South Korea depression screening-mental-health market, Psychological Tests hold the largest market share, significantly contributing to the overall diagnosis landscape. Meanwhile, Blood Tests are emerging as a noteworthy segment, witnessing an increase in adoption due to their ability to provide supporting evidence for diagnosis and treatment evaluation. The diversification within these segments highlights the varying preferences and needs of mental health professionals in their strategies for identifying and treating depression. Growth trends indicate a rising awareness of mental health issues in South Korea, driving the implementation of both Psychological and Blood Tests. Psychological Tests, often recognized for their reliability, are becoming essential tools in clinical settings. On the other hand, Blood Tests are gaining traction, supported by technological advancements and increasing emphasis on precision medicine, which fuel consumer interest and trust in these testing methodologies. Psychological Tests (Dominant) vs. Blood Tests (Emerging) Psychological Tests dominate the diagnosis segment, leveraged for their established reliability and comprehensiveness in assessing mental health conditions. Their standardized nature allows for effective evaluations, often serving as the first line of assessment in clinical settings. Contrarily, Blood Tests represent an emerging trend within the market, appealing to those seeking innovative and scientifically-backed methods for depression screening. This segment is characterized by advancements in biomarker research and increasing clinician reliance on integrative approaches to treatment, creating a notable shift towards hybrid testing methodologies that combine both traditional psychological assessments and emerging blood-based diagnostics. ### By End User: Hospitals and Clinics (Largest) vs. Home-based (Fastest-Growing) In the South Korea depression screening-mental-health market, the Hospitals and Clinics segment captures the largest market share, supported by a robust infrastructure and wide accessibility. This segment benefits from established trust in healthcare providers and comprehensive treatment options, contributing to its dominance. In contrast, the Home-based segment is rapidly gaining traction, appealing to individuals seeking convenience and privacy in managing their mental health. The growth of the Home-based segment is propelled by increasing awareness around mental health issues and a shift towards more personalized care. The rising adoption of telehealth services and digital monitoring tools facilitates access to screening and interventions, making it the fastest-growing segment. This growth reflects changing consumer preferences and advancements in technology that support at-home mental health care. Hospitals and Clinics (Dominant) vs. Home-based (Emerging) The Hospitals and Clinics segment represents the dominant force in the South Korea depression screening-mental-health market due to its extensive networks and expert personnel. They provide integrated care pathways, ensuring that patients receive both screening and subsequent treatment effectively. Services offered within this segment include comprehensive evaluations and follow-ups, fostering a strong patient-provider relationship. Conversely, the Home-based segment is emerging as an alternative, capitalizing on technological advancements, including teletherapy and mental health apps. This segment appeals to younger demographics who prefer engaging in mental health management from the comfort of their homes, further driving its growth. Both segments play crucial roles in enhancing mental health awareness and addressing the challenges associated with depression. ## Competitive Benchmarking The depression screening-mental-health market in South Korea is characterized by a dynamic competitive landscape, driven by increasing awareness of mental health issues and the growing demand for accessible screening solutions. Key players such as UnitedHealth Group (US), Cigna (US), and Teladoc Health (US) are strategically positioned to leverage digital health innovations and telehealth services, which are becoming essential in addressing the mental health needs of the population. These companies are focusing on enhancing their service offerings through technology integration, partnerships, and regional expansions, thereby shaping a competitive environment that emphasizes accessibility and quality of care.In terms of business tactics, companies are increasingly localizing their services to better meet the specific needs of South Korean consumers. This localization, coupled with supply chain optimization, allows for more efficient service delivery and improved patient outcomes. The market appears moderately fragmented, with several key players exerting influence, yet the collective strategies of these companies suggest a trend towards consolidation and collaboration, particularly in the realm of digital health solutions. In October UnitedHealth Group (US) announced a partnership with a leading South Korean telehealth provider to enhance its mental health screening services. This strategic move is likely to expand UnitedHealth's reach within the region, allowing for more comprehensive care options and improved patient engagement. The partnership underscores the importance of local collaborations in effectively addressing the unique mental health challenges faced by South Koreans. In September Cigna (US) launched a new digital platform aimed at providing personalized mental health assessments and resources tailored to the South Korean market. This initiative reflects Cigna's commitment to innovation and its understanding of the necessity for culturally relevant mental health solutions. By utilizing advanced analytics and AI, Cigna is positioning itself as a leader in delivering targeted mental health support, which may enhance its competitive edge. In August Teladoc Health (US) expanded its mental health services by integrating AI-driven tools that facilitate real-time screening and intervention. This development is indicative of a broader trend towards the incorporation of technology in mental health care, which not only improves efficiency but also enhances the user experience. Teladoc's focus on AI integration may set a new standard for mental health service delivery in South Korea, potentially influencing other players in the market. As of November the competitive trends in the depression screening-mental-health market are increasingly defined by digitalization, AI integration, and strategic alliances. Companies are recognizing the necessity of forming partnerships to enhance their service offerings and improve patient outcomes. The shift from price-based competition to a focus on innovation and technology is evident, suggesting that future competitive differentiation will hinge on the ability to deliver reliable, high-quality mental health solutions that resonate with the needs of consumers. ## Recent News & Developments Recent developments in the South Korea Depression Screening Mental Health Market highlight a growing need for mental health services amid increasing awareness regarding mental health issues. Asan Medical Center and Seoul National University Hospital have launched new initiatives focusing on early detection and screening for depression, aiming to improve patient outcomes through advanced technology and collaboration with community health organizations. In October 2023, Hallym University Medical Center signed a partnership agreement with Konkuk University Medical Center to enhance mental health services, thereby expanding their capabilities in depression screening and treatment. Moreover, the Korean Institute of Mental Health has reported significant growth in the market due to government support for mental health initiatives, with funding aimed at boosting research and development in this sector. Current affairs also reveal that Samsung Medical Center is incorporating artificial intelligence tools into their screening processes, promising higher accuracy and efficiency. Over the past few years, the South Korean government has prioritized mental health, responding to increasing depression ratesevidenced by a reported increase in patients seeking help at facilities like the Daejeon Mental Health Center and Chonnam National University Hospital, emphasizing the urgent need for expanded services and resources. ## Report Scope | MARKET SIZE 2024 | 18.26(USD Million) | | --- | --- | | MARKET SIZE 2025 | 19.02(USD Million) | | MARKET SIZE 2035 | 28.56(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.15% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | UnitedHealth Group (US), Anthem (US), Cigna (US), Kaiser Permanente (US), Teladoc Health (US), Mayo Clinic (US), HCA Healthcare (US), Cerner Corporation (US), McKesson Corporation (US) | | Segments Covered | Indication, Diagnosis, End User | | Key Market Opportunities | Integration of digital tools for enhanced depression screening and personalized mental health interventions. | | Key Market Dynamics | Rising demand for digital mental health solutions drives innovation in depression screening methodologies and technologies. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What was the market valuation of the South Korea depression screening-mental-health market in 2024?** A: The market valuation was $18.26 Million in 2024. **Q: What is the projected market valuation for the South Korea depression screening-mental-health market in 2035?** A: The projected market valuation for 2035 is $28.56 Million. **Q: What is the expected CAGR for the South Korea depression screening-mental-health market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 4.15%. **Q: Which key players are leading the South Korea depression screening-mental-health market?** A: Key players include UnitedHealth Group, Anthem, Cigna, Kaiser Permanente, Teladoc Health, Mayo Clinic, HCA Healthcare, Cerner Corporation, and McKesson Corporation. **Q: What segment had the highest valuation in the South Korea depression screening-mental-health market in 2024?** A: The 'Indication' segment, particularly Major Depressive Disorder, had the highest valuation at $11.5 Million. **Q: What is the projected growth for the Psychological Tests segment in the South Korea depression screening-mental-health market?** A: The Psychological Tests segment is projected to grow from $7.0 Million to $10.5 Million by 2035. **Q: How does the Home-based end-user segment compare to Hospitals and Clinics in terms of market valuation?** A: In 2024, the Hospitals and Clinics segment was valued at $12.0 Million, while the Home-based segment was valued at $8.0 Million. **Q: What is the expected growth for the Bipolar Disorder segment in the South Korea depression screening-mental-health market?** A: The Bipolar Disorder segment is expected to grow from $2.5 Million to $4.0 Million by 2035. **Q: What types of diagnostic tests are included in the South Korea depression screening-mental-health market?** A: Diagnostic tests include Psychological Tests, Blood Tests, and Pharmacogenomic Testing, with respective valuations of $10.5 Million, $6.0 Million, and $5.0 Million by 2035. **Q: What is the significance of research and academic institutes as an end-user segment in the market?** A: The Research and Academic Institutes segment is projected to grow from $5.26 Million to $8.56 Million by 2035, indicating its increasing role in mental health research. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-depression-screening-mental-health-market-56282*